A detailed history of D. E. Shaw & Co., Inc. transactions in Adma Biologics, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 5,264,095 shares of ADMA stock, worth $111 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
5,264,095
Holding current value
$111 Million
% of portfolio
0.1%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$11.21 - $20.03 $17.5 Million - $31.3 Million
-1,560,422 Reduced 22.86%
5,264,095 $105 Million
Q2 2024

Aug 14, 2024

BUY
$5.98 - $11.18 $8.63 Million - $16.1 Million
1,442,799 Added 26.81%
6,824,517 $76.3 Million
Q1 2024

May 15, 2024

SELL
$4.4 - $6.74 $4.98 Million - $7.63 Million
-1,131,835 Reduced 17.38%
5,381,718 $35.5 Million
Q4 2023

Feb 14, 2024

SELL
$3.08 - $4.52 $3.26 Million - $4.78 Million
-1,058,140 Reduced 13.97%
6,513,553 $29.4 Million
Q3 2023

Nov 14, 2023

SELL
$3.47 - $4.61 $2.09 Million - $2.78 Million
-602,124 Reduced 7.37%
7,571,693 $27.1 Million
Q2 2023

Aug 14, 2023

SELL
$3.12 - $4.22 $117,798 - $159,330
-37,756 Reduced 0.46%
8,173,817 $30.2 Million
Q1 2023

May 15, 2023

SELL
$3.01 - $3.87 $893,476 - $1.15 Million
-296,836 Reduced 3.49%
8,211,573 $27.2 Million
Q4 2022

Feb 14, 2023

BUY
$2.47 - $3.88 $6.58 Million - $10.3 Million
2,664,613 Added 45.6%
8,508,409 $33 Million
Q3 2022

Nov 14, 2022

BUY
$2.03 - $2.86 $2.05 Million - $2.89 Million
1,011,404 Added 20.93%
5,843,796 $14.2 Million
Q2 2022

Aug 15, 2022

BUY
$1.43 - $2.2 $4.19 Million - $6.45 Million
2,930,104 Added 154.03%
4,832,392 $9.57 Million
Q1 2022

May 16, 2022

BUY
$1.28 - $1.83 $2.32 Million - $3.32 Million
1,812,981 Added 2030.05%
1,902,288 $3.48 Million
Q4 2021

Feb 14, 2022

BUY
$1.09 - $1.66 $97,344 - $148,249
89,307 New
89,307 $126,000
Q3 2021

Nov 15, 2021

SELL
$1.13 - $1.65 $239,211 - $349,291
-211,692 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$1.51 - $2.07 $319,654 - $438,202
211,692 New
211,692 $339,000
Q4 2020

Feb 16, 2021

SELL
$1.8 - $2.56 $18,054 - $25,676
-10,030 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$2.04 - $3.74 $20,461 - $37,512
10,030 New
10,030 $24,000

Others Institutions Holding ADMA

About ADMA BIOLOGICS, INC.


  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $4.16B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.